Free Trial

Moringa Acquisition (MACA) Competitors

GBX 175 0.00 (0.00%)
As of 05/21/2025

MACA vs. EARN, ORM, OSI, NNN, PEL, RENE, PPHP, MAC, EVE, and BRD

Should you be buying Moringa Acquisition stock or one of its competitors? The main competitors of Moringa Acquisition include EARNZ (EARN), Ormonde Mining (ORM), Osirium Technologies (OSI), nanosynth group (NNN), Paragon Entertainment (PEL), ReNeuron Group (RENE), Papillon (PPHP), Marechale Capital (MAC), eve Sleep (EVE), and BlueRock Diamonds (BRD). These companies are all part of the "trading" industry.

Moringa Acquisition vs.

EARNZ (LON:EARN) and Moringa Acquisition (LON:MACA) are both small-cap financial services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

EARNZ and Moringa Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
EARNZN/AN/A
Moringa AcquisitionN/AN/A

Moringa Acquisition has a net margin of 0.00% compared to EARNZ's net margin of -466.55%. Moringa Acquisition's return on equity of 0.00% beat EARNZ's return on equity.

Company Net Margins Return on Equity Return on Assets
EARNZ-466.55% -116.64% -43.59%
Moringa Acquisition N/A N/A N/A

Moringa Acquisition has lower revenue, but higher earnings than EARNZ.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EARNZ£974.54K3.15-£4.55M-£4.45-0.67
Moringa AcquisitionN/AN/AN/AN/AN/A

39.7% of EARNZ shares are held by institutional investors. 30.0% of EARNZ shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, EARNZ's average media sentiment score of 0.00 equaled Moringa Acquisition'saverage media sentiment score.

Company Overall Sentiment
EARNZ Neutral
Moringa Acquisition Neutral

Summary

EARNZ and Moringa Acquisition tied by winning 3 of the 6 factors compared between the two stocks.

Get Moringa Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for MACA and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MACA vs. The Competition

MetricMoringa AcquisitionInvestment Offices IndustryFinance SectorLON Exchange
Market Cap£1.23M£195.23M£11.47B£2.62B
Dividend YieldN/AN/A5.44%5.05%
P/E RatioN/AN/A22.42129.34
Price / SalesN/AN/A27.62221,585.85
Price / CashN/AN/A17.6228.03
Price / BookN/AN/A2.773.79
Net IncomeN/AN/A£1.03B£5.88B
7 Day PerformanceN/A0.00%-0.23%0.62%
1 Month PerformanceN/A1.86%6.11%22.12%
1 Year PerformanceN/A33.83%536.61%120.95%

Moringa Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MACA
Moringa Acquisition
N/AGBX 175
flat
N/AN/A£1.23MN/A0.003High Trading Volume
EARN
EARNZ
N/AGBX 4
-1.2%
N/A-60.4%£4.09M£974,537.57-0.9011Gap Down
ORM
Ormonde Mining
N/AN/AN/AN/A£3.54MN/A-2.506
OSI
Osirium Technologies
N/AN/AN/AN/A£2.70M£2.09M-110.003
NNN
nanosynth group
N/AN/AN/AN/A£2.58M£85,650.00-1.1280High Trading Volume
PEL
Paragon Entertainment
N/AN/AN/AN/A£2.37M£10.84M-0.9682,400Gap Down
RENE
ReNeuron Group
N/AN/AN/AN/A£1.93M£783,000.00-37.502Gap Down
PPHP
Papillon
N/AN/AN/AN/A£1.75MN/A0.003Gap Up
MAC
Marechale Capital
N/AGBX 1.40
flat
N/A-8.3%£1.47M£662,579.57-8.03650Gap Down
EVE
eve Sleep
N/AN/AN/AN/A£1.44M£24.29M-0.484Gap Up
BRD
BlueRock Diamonds
N/AN/AN/AN/A£929,000.00£9.12M-225.00100

Related Companies and Tools


This page (LON:MACA) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners